✦ LIBER ✦

Prevalence and evolution of drug resistance HIV-1 variants in Henan, China

✍ Scribed by LI, Jing Yun; LI, Han Ping; LI, Lin; LI, Hong; WANG, Zhe; YANG, Kun; BAO, Zuo Yi; ZHUANG, Dao Min; LIU, Si Yang; LIU, Yong Jian

Book ID: 110020684
Publisher: Nature Publishing Group
Year: 2005
Tongue: English
Weight: 41 KB
Volume: 15
Category: Article
ISSN: 0007-0610
DOI: 10.1038/sj.cr.7290356

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Commentary on “Prevalence and evolution

Commentary on “Prevalence and evolution of drug resistance HIV-1 variants in Henan, China”

✍ GILLIAM, Bruce L; REDFIELD, Robert R; ZHAO, Richard Y; GALLO, Robert C 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 22 KB

Replicative fitness in vivo of HIV-1 var

Replicative fitness in vivo of HIV-1 variants with multiple drug resistance-associated mutations

✍ Helen L. Devereux; Vincent C. Emery; Margaret A. Johnson; Clive Loveday 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

## Abstract The relative fitness of HIV‐1 viral variants containing a broad range of drug resistance‐associated mutations has been little studied in vivo. Understanding the relative fitness associated with viruses containing mutations may aid future therapeutic management. The aim of this study was

Prevalence and Correlates of HIV Risk Be

Prevalence and Correlates of HIV Risk Behaviors among Drug Users in China

✍ Xiushi Yang; Carl Latkin; David Celentano; Huasong Luo 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 203 KB

Low prevalence of transmitted drug resis

Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia

✍ Dace Balode; Maj Westman; Tatjana Kolupajeva; Baiba Rozentale; Jan Albert 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

## Abstract Transmitted drug resistance (TDR) is a concern because it may reduce the efficacy of antiretroviral treatment. Plasma samples of 119 HIV‐1‐infected patients who were newly diagnosed at the Infectology Center of Latvia in 2005 and 2006 were analyzed by an in‐house genotypic resistance as

Recombination favors the evolution of dr

Recombination favors the evolution of drug resistance in HIV-1 during antiretroviral therapy

✍ Antonio Carvajal-Rodríguez; Keith A. Crandall; David Posada 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 568 KB

We studied the relationship between recombination and the fixation time of multiple drug resistance mutations after HIV-1 drug therapy, under a set of different realistic scenarios. We have generalized a previous model by Bretscher et al. [Bretscher, Althaus, Muller, Bonhoeffer, 2004. Recombination

Low Prevalence of Antiretroviral Drug Re

Low Prevalence of Antiretroviral Drug Resistance among HIV-1 Seroconverters in London, 1984–1991

✍ P.J Easterbrook; K Hertogs; A Waters; B Wills; B.G Gazzard; B Larder 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 79 KB